Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose IV Busulfan + Melphalan Conditioning for Transplant
NCT00427765Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2004
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of busulfan in lymphoma, multiple myeloma (MM), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2004; status: completed.
02
Drugs
busulfan
03
Conditions
lymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on NCT00427765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00427765.